title: Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update.
abstract: Chronic obstructive pulmonary disease (COPD) is a major respiratory illness in Canada that is both preventable and treatable. Our understanding of the pathophysiology of this complex condition continues to grow and our ability to offer effective treatment to those who suffer from it has improved considerably. The purpose of the present educational initiative of the Canadian Thoracic Society (CTS) is to provide up to date information on new developments in the field so that patients with this condition will receive optimal care that is firmly based on scientific evidence. Since the previous CTS management recommendations were published in 2003, a wealth of new scientific information has become available. The implications of this new knowledge with respect to optimal clinical care have been carefully considered by the CTS Panel and the conclusions are presented in the current document. Highlights of this update include new epidemiological information on mortality and prevalence of COPD, which charts its emergence as a major health problem for women; a new section on common comorbidities in COPD; an increased emphasis on the meaningful benefits of combined pharmacological and nonpharmacological therapies; and a new discussion on the prevention of acute exacerbations. A revised stratification system for severity of airway obstruction is proposed, together with other suggestions on how best to clinically evaluate individual patients with this complex disease. The results of the largest randomized clinical trial ever undertaken in COPD have recently been published, enabling the Panel to make evidence-based recommendations on the role of modern pharmacotherapy. The Panel hopes that these new practice guidelines, which reflect a rigorous analysis of the recent literature, will assist caregivers in the diagnosis and management of this common condition.
authors: Queen's University, Kingston, Canada.
authors: Denis E
authors: DE
authors: O'Donnell
authors: Shaw
authors: S
authors: Aaron
authors: Jean
authors: J
authors: Bourbeau
authors: Paul
authors: P
authors: Hernandez
authors: Darcy D
authors: DD
authors: Marciniuk
authors: Meyer
authors: M
authors: Balter
authors: Gordon
authors: G
authors: Ford
authors: Andre
authors: A
authors: Gervais
authors: Rogers
authors: R
authors: Goldstein
authors: Rick
authors: R
authors: Hodder
authors: Alan
authors: A
authors: Kaplan
authors: Sean
authors: S
authors: Keenan
authors: Yves
authors: Y
authors: Lacasse
authors: Francois
authors: F
authors: Maltais
authors: Jeremy
authors: J
authors: Road
authors: Graeme
authors: G
authors: Rocker
authors: Don
authors: D
authors: Sin
authors: Tasmin
authors: T
authors: Sinuff
authors: Nha
authors: N
authors: Voduc
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002170:Canada; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010102:Oxygen Inhalation Therapy; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000534:rehabilitation* / Q000601:surgery; D016540:Smoking Cessation
chemical_list: D000305:Adrenal Cortex Hormones; D001993:Bronchodilator Agents